Rare 2q34 Chromosome Deletion Shows No Neurodevelopmental Impact at One Year
New Insights into 2q34 Deletions and Early Childhood Development
A recent case study has identified a rare genetic deletion on chromosome 2q34 that, contrary to previous associations, did not lead to neurodevelopmental issues in an infant during the first year of life. This finding adds nuance to our understanding of the genetic factors involved in developmental disorders.
Details of the Genetic Deletion
The deletion, measuring 1.62 megabases (Mb), was detected prenatally in a fetus through amniocentesis performed at 19 weeks of gestation. Advanced copy number variation sequencing (CNV-seq) revealed that the deletion was de novo, meaning it was not inherited from either parent. This chromosomal segment includes three protein-coding genes: LANCL1, CPS1, and ERBB4.
Clinical and Developmental Follow-Up
Serial prenatal ultrasounds showed mostly normal development, with only a mild and temporary slowing in head growth. The infant was born at term without any physical abnormalities. By 12 months of age, the child exhibited typical physical growth, motor skills, and cognitive development. Notably, the head circumference had returned to a normal range.
Context and Implications
Deletions in the 2q34 region, especially those involving the ERBB4 gene, have previously been linked to neurodevelopmental disorders such as intellectual disability, epilepsy, autism spectrum disorder, and behavioral challenges. However, this case suggests that the presence of such a deletion does not invariably result in these conditions, indicating incomplete penetrance and variable expressivity.
These findings underscore the complexity of predicting clinical outcomes based solely on genetic deletions and highlight the importance of long-term monitoring to fully understand the phenotypic consequences.
Considerations for Families and Clinicians
For families receiving a prenatal diagnosis of a 2q34 deletion, this report offers a cautiously optimistic perspective. While some deletions in this region have been associated with developmental challenges, this case demonstrates that normal development is possible. It is important for healthcare providers to communicate the potential variability in outcomes and recommend ongoing developmental assessments.
Limitations and Future Directions
As this report covers follow-up only up to 12 months, longer-term studies are necessary to determine if neurodevelopmental issues might emerge later. Additionally, the rarity of such deletions means that broader studies are needed to better define the range of possible outcomes and establish more precise genotype-phenotype correlations.
For further details, see the original study published in Psychiatric Genetics: https://pubmed.ncbi.nlm.nih.gov/42704312/.
Download the images in this article
